Anna‐Karin Roos

494 total citations
8 papers, 386 citations indexed

About

Anna‐Karin Roos is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, Anna‐Karin Roos has authored 8 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Biotechnology and 1 paper in Molecular Biology. Recurrent topics in Anna‐Karin Roos's work include Transgenic Plants and Applications (5 papers), Microbial Inactivation Methods (5 papers) and Immunotherapy and Immune Responses (4 papers). Anna‐Karin Roos is often cited by papers focused on Transgenic Plants and Applications (5 papers), Microbial Inactivation Methods (5 papers) and Immunotherapy and Immune Responses (4 papers). Anna‐Karin Roos collaborates with scholars based in Sweden, United States and Germany. Anna‐Karin Roos's co-authors include Pavel Pisa, Alan King, Maxim Pavlenko, Fredrik Eriksson, Christoph Leder, Andreas Bråve, Sonia Carreño-Moreno, Britta Wahrén, Ulrika Nyman and James A. Timmons and has published in prestigious journals such as PLoS ONE, Vaccine and Molecular Therapy.

In The Last Decade

Anna‐Karin Roos

8 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna‐Karin Roos Sweden	7	222	184	144	54	38	8	386
Mary Giffear United States	3	185 0.8×	62 0.3×	79 0.5×	108 2.0×	62 1.6×	5	307
G. É. El'kin United States	9	86 0.4×	140 0.8×	186 1.3×	35 0.6×	69 1.8×	16	324
Frances E. Pearson Australia	13	343 1.5×	46 0.3×	125 0.9×	40 0.7×	73 1.9×	16	560
J M Ruehlmann United States	7	281 1.3×	119 0.6×	162 1.1×	26 0.5×	46 1.2×	8	427
Nuno Viegas Germany	7	213 1.0×	186 1.0×	72 0.5×	109 2.0×	37 1.0×	7	487
Reina Jordens Netherlands	8	346 1.6×	23 0.1×	185 1.3×	50 0.9×	36 0.9×	8	481
Sudhirdas Prayaga United States	4	204 0.9×	22 0.1×	179 1.2×	91 1.7×	60 1.6×	5	389
Marija Zaric United Kingdom	10	248 1.1×	32 0.2×	131 0.9×	44 0.8×	40 1.1×	12	511
Zhenqian Guo China	6	100 0.5×	21 0.1×	211 1.5×	60 1.1×	61 1.6×	6	367
Byung Chul Jeong South Korea	5	124 0.6×	24 0.1×	180 1.3×	28 0.5×	34 0.9×	8	374

Countries citing papers authored by Anna‐Karin Roos

Since Specialization

Citations

This map shows the geographic impact of Anna‐Karin Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna‐Karin Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna‐Karin Roos more than expected).

Fields of papers citing papers by Anna‐Karin Roos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna‐Karin Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna‐Karin Roos. The network helps show where Anna‐Karin Roos may publish in the future.

Co-authorship network of co-authors of Anna‐Karin Roos

This figure shows the co-authorship network connecting the top 25 collaborators of Anna‐Karin Roos. A scholar is included among the top collaborators of Anna‐Karin Roos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna‐Karin Roos. Anna‐Karin Roos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bråve, Andreas, Sanna Nyström, Anna‐Karin Roos, & Steven E. Applequist. (2010). Plasmid DNA vaccination using skin electroporation promotes poly‐functional CD4 T‐cell responses. Immunology and Cell Biology. 89(3). 492–496. 32 indexed citations

2.

Roos, Anna‐Karin, et al.. (2009). Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients. Molecular Therapy. 17(9). 1637–1642. 60 indexed citations

3.

Roos, Anna‐Karin, Maxim Pavlenko, Christoph Leder, et al.. (2009). A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols. Vaccine. 27(10). 1557–1565. 4 indexed citations

4.

Roos, Anna‐Karin, Fredrik Eriksson, James A. Timmons, et al.. (2009). Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment. PLoS ONE. 4(9). e7226–e7226. 116 indexed citations

5.

Roos, Anna‐Karin, Alan King, & Pavel Pisa. (2008). DNA Vaccination for Prostate Cancer. Methods in molecular biology. 423. 463–472. 10 indexed citations

6.

Pavlenko, Maxim, Christoph Leder, Anna‐Karin Roos, Victor Levitsky, & Pavel Pisa. (2005). Identification of an immunodominant H‐2D^b‐restricted CTL epitope of human PSA. The Prostate. 64(1). 50–59. 20 indexed citations

7.

Roos, Anna‐Karin, Sonia Carreño-Moreno, Christoph Leder, et al.. (2005). Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Molecular Therapy. 13(2). 320–327. 102 indexed citations

8.

Roos, Anna‐Karin, Maxim Pavlenko, Jehad Charo, Lars Egevad, & Pavel Pisa. (2004). Induction of PSA‐specific CTLs and anti‐tumor immunity by a genetic prostate cancer vaccine. The Prostate. 62(3). 217–223. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact